Ready Retirement Report - Investing and Stock News
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Ready Retirement Report - Investing and Stock News
No Result
View All Result
Home Latest News

Trump bans federal funding for ‘dangerous’ gain-of-function research

by
May 5, 2025
in Latest News
0
Trump bans federal funding for ‘dangerous’ gain-of-function research
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

President Donald Trump signed an executive order on Monday banning all federal funding for ‘dangerous’ gain-of-function research in China, Iran and other countries and blocking all federal funding for foreign research that could cause another pandemic. 

The president signed the order Monday afternoon to improve the safety and security of biological research in the U.S. and around the world. 

The White House said the order ‘will drastically reduce the potential for lab-related incidents involving gain-of-function research, like that conducted on bat coronaviruses in China by the EcoHealth Alliance and Wuhan Institute of Virology.’ 

Gain-of-function research typically involves modifying a virus to make it more infectious among humans. Gain of function research took place at the Wuhan Lab before the COVID-19 pandemic began. 

The White House said the order will protect Americans from lab accidents and other biosecurity incidents, ‘such as those that likely caused COVID-19 and the 1977 Russian flu.’ 

The president’s order ends any present and all future federal funding of gain-of-function research in countries with insufficient oversight of research, and it empowers U.S. research agencies to identify and end federal funding of any other biological research that could pose a threat to American public health, public safety or national security. 

‘For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight,’ the White House said in a fact sheet describing the order. ‘Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.’ 

The order, according to the White House, ‘protects Americans from dangerous gain-of-function research that manipulates viruses and other biological agents and toxins, but it does not impede productive biological research that will ensure the United States maintains readiness against biological threats and continues to drive global leadership in biotechnology, biosecurity, and health research.’ 

‘President Trump has long theorized that COVID-19 originated from a lab leak at the Wuhan Institute of Virology and has consistently pushed for transparency in investigating its origins,’ the White House said. 

This is a developing story. Please check back for updates. 

This post appeared first on FOX NEWS
Previous Post

Israel strikes Yemen’s port city in response to Houthi attack on Tel Aviv Airport

Next Post

Trump-aligned group sues Chief Justice John Roberts in effort to restrict power of the courts

Next Post
Trump-aligned group sues Chief Justice John Roberts in effort to restrict power of the courts

Trump-aligned group sues Chief Justice John Roberts in effort to restrict power of the courts

  • Trending
  • Comments
  • Latest
McDonald’s where Trump served fries hit with flurry of bad Yelp reviews

McDonald’s where Trump served fries hit with flurry of bad Yelp reviews

October 23, 2024
The practical and moral difficulties of deporting millions draw closer

The practical and moral difficulties of deporting millions draw closer

October 23, 2024
Trump supporters are more likely to expect a collapse into fascism

Trump supporters are more likely to expect a collapse into fascism

October 23, 2024
Obama rallies with Walz in Wisconsin: ‘America is ready to turn the page’

Obama rallies with Walz in Wisconsin: ‘America is ready to turn the page’

October 22, 2024
Fintech company Chime files for Nasdaq IPO

Fintech company Chime files for Nasdaq IPO

0
Trump attacks Harris with racist stereotype, eyes ‘extreme power’ as president

Trump attacks Harris with racist stereotype, eyes ‘extreme power’ as president

0
Kamala Harris’s narrow opening with GOP-leaning voters

Kamala Harris’s narrow opening with GOP-leaning voters

0
Obama rallies with Walz in Wisconsin: ‘America is ready to turn the page’

Obama rallies with Walz in Wisconsin: ‘America is ready to turn the page’

0
Fintech company Chime files for Nasdaq IPO

Fintech company Chime files for Nasdaq IPO

May 14, 2025
House Republicans face down Dem attacks, protests to pull all-nighter on Trump’s ‘big, beautiful bill’

House Republicans face down Dem attacks, protests to pull all-nighter on Trump’s ‘big, beautiful bill’

May 14, 2025
Father and son fraudsters sentenced in case of $100 million New Jersey deli

Father and son fraudsters sentenced in case of $100 million New Jersey deli

May 13, 2025
UnitedHealth CEO suddenly steps down for ‘personal reasons’

UnitedHealth CEO suddenly steps down for ‘personal reasons’

May 13, 2025
Enter Your Information Below To Receive Trading Ideas and Latest News

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent News

    Fintech company Chime files for Nasdaq IPO

    Fintech company Chime files for Nasdaq IPO

    May 14, 2025
    House Republicans face down Dem attacks, protests to pull all-nighter on Trump’s ‘big, beautiful bill’

    House Republicans face down Dem attacks, protests to pull all-nighter on Trump’s ‘big, beautiful bill’

    May 14, 2025
    Father and son fraudsters sentenced in case of $100 million New Jersey deli

    Father and son fraudsters sentenced in case of $100 million New Jersey deli

    May 13, 2025
    UnitedHealth CEO suddenly steps down for ‘personal reasons’

    UnitedHealth CEO suddenly steps down for ‘personal reasons’

    May 13, 2025
    • About Us
    • Contact Us
    • Email Whitelisting
    • Privacy Policy
    • Terms and Conditions
    • About Us
    • Contact Us
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy

    All Rights Reserved © 2024 Readyretirementreport.com

    No Result
    View All Result
    • Investing
    • Latest News
    • Editor’s Pick
    • Economy

    All Rights Reserved © 2024 Readyretirementreport.com